Infinity Pharmaceuticals Statistics
Infinity Pharmaceuticals (INFIQ) Stock Statistics & Valuation Metrics
Total Valuation
Infinity Pharmaceuticals has a market cap or net worth of $91.00. The enterprise value is $49.63M.
- Market Cap
- $91.00
- Enterprise Value
- $49.63M
Share Statistics
Infinity Pharmaceuticals has 90,761,080 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 90,761,080
- Owned by Insiders
- ―
- Owned by Institutions
- 0.03%
Financial Efficiency
Infinity Pharmaceuticals’s return on equity (ROE) is 2.33 and return on invested capital (ROIC) is -154.02%.
- Return on Equity (ROE)
- 2.33
- Return on Assets (ROA)
- -1.05
- Return on Invested Capital (ROIC)
- -154.02%
- Return on Capital Employed (ROCE)
- -1.57
- Revenue Per Employee
- 86.43K
- Profits Per Employee
- -1.48M
- Employee Count
- 30
- Asset Turnover
- 0.06
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Infinity Pharmaceuticals is -0.00. Infinity Pharmaceuticals’s PEG ratio is 0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- -0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Infinity Pharmaceuticals had revenue of 2.59M and earned -44.37M in profits. Earnings per share was -0.50.
- Revenue
- 2.59M
- Gross Profit
- 1.03M
- Operating Income
- -44.84M
- Pretax Income
- -44.37M
- Net Income
- -44.37M
- EBITDA
- -43.73M
- Earnings Per Share (EPS)
- -0.50
Cash Flow
In the last 12 months, operating cash flow was -38.88M and capital expenditures 0, giving a free cash flow of -38.88M billion.
- Operating Cash Flow
- -38.88M
- Free Cash Flow
- -38.88M
- Free Cash Flow per Share
- -0.48
Dividends & Yields
Infinity Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -467695.02%
- Earnings Yield
- -497143.99%
Stock Price Statistics
- Beta
- -110.71
- 52-Week Price Change
- -98.66%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Infinity Pharmaceuticals upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Mar 14, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Infinity Pharmaceuticals as a current ratio of 2.96, with Debt / Equity ratio of -252.64%
- Current Ratio
- 2.96
- Quick Ratio
- 2.96
- Debt to Market Cap
- 0.95
- Net Debt to EBITDA
- -0.22
- Interest Coverage Ratio
- -249.13
Taxes
In the past 12 months, Infinity Pharmaceuticals has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Infinity Pharmaceuticals EV to EBITDA ratio is -0.22, with an EV/FCF ratio of -0.23.
- EV to Sales
- 3.79
- EV to EBITDA
- -0.22
- EV to Free Cash Flow
- -0.23
- EV to Operating Cash Flow
- -0.23
Balance Sheet
Infinity Pharmaceuticals has $17.75M in cash and marketable securities with $633.00K in debt, giving a net cash position of $17.11M billion.
- Cash & Marketable Securities
- $17.75M
- Total Debt
- $633.00K
- Net Cash
- $17.11M
- Net Cash Per Share
- $0.19
- Tangible Book Value Per Share
- -$0.42
Margins
Gross margin is 39.72%, with operating margin of -1729.43%, and net profit margin of -1711.11%.
- Gross Margin
- 39.72%
- Operating Margin
- -1729.43%
- Pretax Margin
- -1711.11%
- Net Profit Margin
- -1711.11%
- EBITDA Margin
- -1686.50%
- EBIT Margin
- -1704.17%
